JERUSALEM, Israel--(BUSINESS WIRE)--BioLineRx Ltd. (TASE: BLRX), Israel’s leading drug development company, announced today that Morris C. Laster, MD, CEO, will present a company overview at the BIO CEO & Investor Conference 2007 on Tuesday, February 13, 2007, at 4:30 PM ET at The Waldorf=Astoria Hotel in New York City.
